Global Pediatric Vaccine Market 2019-2023
The market contains a significant number of monotherapy and combination
therapy-based vaccines that are currently under the late stages of
development and are expected to get approved during the forecast period.
For instance, Pertagen is a recombinant vaccine that is in the
registration phase for immunization against pertussis in children aged
11 years and above. These vaccines possess a strong therapeutic
potential for the prevention of a large number of infectious diseases
and allergies in children. Hence, these products have a fair chance of
entering the market during the forecast period. Furthermore, the
recently approved vaccines for pediatric health are also driving market
growth.
As per Technavio, the development of vaccines for unmet medical conditions will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global pediatric vaccine market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
Global pediatric vaccine market: Development of vaccines for unmet medical conditions
There are several unmet medical conditions such as HIV, malaria, tuberculosis, dengue, Ebola, H1N1, H5N1, cancer, and various allergic conditions. Significant advances in molecular biology and computational biology have made it possible to develop novel vaccines based on adjuvants, vectors, nucleic acids, and structure-based antigen design. Moreover, the leading manufacturers, in partnership with government bodies, have initiated the development of innovative vaccines owing to the availability of advanced procedures. Thus, such initiatives are expected to help the overall global pediatric vaccine market during the forecast period.
Global pediatric vaccine market: Segmentation
analysis
This market research report segments the global pediatric vaccine market by product (conjugate vaccines and others, live-attenuated vaccines, toxoid vaccines, inactivated vaccines) and geographical regions (North America, Europe, Asia, and ROW).
As per Technavio, the development of vaccines for unmet medical conditions will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global pediatric vaccine market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
Global pediatric vaccine market: Development of vaccines for unmet medical conditions
There are several unmet medical conditions such as HIV, malaria, tuberculosis, dengue, Ebola, H1N1, H5N1, cancer, and various allergic conditions. Significant advances in molecular biology and computational biology have made it possible to develop novel vaccines based on adjuvants, vectors, nucleic acids, and structure-based antigen design. Moreover, the leading manufacturers, in partnership with government bodies, have initiated the development of innovative vaccines owing to the availability of advanced procedures. Thus, such initiatives are expected to help the overall global pediatric vaccine market during the forecast period.
This market research report segments the global pediatric vaccine market by product (conjugate vaccines and others, live-attenuated vaccines, toxoid vaccines, inactivated vaccines) and geographical regions (North America, Europe, Asia, and ROW).
Comments
Post a Comment